Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1973 1
1978 1
1981 1
1983 1
1987 2
1988 2
1989 1
1990 7
1991 3
1992 2
1993 6
1994 6
1995 8
1996 14
1997 19
1998 8
1999 15
2000 16
2001 22
2002 22
2003 30
2004 39
2005 51
2006 54
2007 69
2008 54
2009 88
2010 86
2011 109
2012 115
2013 129
2014 170
2015 170
2016 174
2017 167
2018 168
2019 139
2020 134
2021 129
2022 136
2023 151
2024 137
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,366 results

Results by year

Filters applied: . Clear all
Page 1
Chronic thromboembolic pulmonary hypertension.
Kim NH, Delcroix M, Jais X, Madani MM, Matsubara H, Mayer E, Ogo T, Tapson VF, Ghofrani HA, Jenkins DP. Kim NH, et al. Eur Respir J. 2019 Jan 24;53(1):1801915. doi: 10.1183/13993003.01915-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30545969 Free PMC article. Review.
Riociguat for the treatment of chronic thromboembolic pulmonary hypertension.
Ghofrani HA, D'Armini AM, Grimminger F, Hoeper MM, Jansa P, Kim NH, Mayer E, Simonneau G, Wilkins MR, Fritsch A, Neuser D, Weimann G, Wang C; CHEST-1 Study Group. Ghofrani HA, et al. Among authors: kim nh. N Engl J Med. 2013 Jul 25;369(4):319-29. doi: 10.1056/NEJMoa1209657. N Engl J Med. 2013. PMID: 23883377 Free article. Clinical Trial.
Chronic thromboembolic pulmonary disease.
Kim NH, D'Armini AM, Delcroix M, Jaïs X, Jevnikar M, Madani MM, Matsubara H, Palazzini M, Wiedenroth CB, Simonneau G, Jenkins DP. Kim NH, et al. Eur Respir J. 2024 Oct 31;64(4):2401294. doi: 10.1183/13993003.01294-2024. Print 2024 Oct. Eur Respir J. 2024. PMID: 39209473 Free PMC article. Review.
Síndrome post-tromboembolismo pulmonar, EPTEC, y HPTEC.
Porres-Aguilar M, Rivera-Lebron B, Kim NH, Solomon AL, Ratchford EV, Heresi GA. Porres-Aguilar M, et al. Among authors: kim nh. Vasc Med. 2024 Aug;29(4):NP1-NP5. doi: 10.1177/1358863X241264222. Vasc Med. 2024. PMID: 39135267 No abstract available.
Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy.
Delcroix M, Pepke-Zaba J, D'Armini AM, Fadel E, Guth S, Hoole SP, Jenkins DP, Kiely DG, Kim NH, Madani MM, Matsubara H, Nakayama K, Ogawa A, Ota-Arakaki JS, Quarck R, Sadushi-Kolici R, Simonneau G, Wiedenroth CB, Yildizeli B, Mayer E, Lang IM. Delcroix M, et al. Among authors: kim nh. Circulation. 2024 Oct 22;150(17):1354-1365. doi: 10.1161/CIRCULATIONAHA.124.068610. Epub 2024 Sep 17. Circulation. 2024. PMID: 39286890 Free PMC article.
A multicentre, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozin.
Lim S, Lee SH, Min KW, Lee CB, Kim SY, Yoo HJ, Kim NH, Kim JH, Oh S, Won JC, Kwon HS, Kim MK, Park JH, Jeong IK, Kim S. Lim S, et al. Among authors: kim nh. Diabetes Obes Metab. 2024 Jun;26(6):2188-2198. doi: 10.1111/dom.15526. Epub 2024 Feb 29. Diabetes Obes Metab. 2024. PMID: 38425186 Clinical Trial.
Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry).
McLaughlin V, Farber HW, Highland KB, Hemnes AR, Chakinala MM, Chin KM, Han M, Cho M, Tobore T, Rahman M, Kim NH. McLaughlin V, et al. Among authors: kim nh. J Heart Lung Transplant. 2024 Feb;43(2):272-283. doi: 10.1016/j.healun.2023.09.016. Epub 2023 Sep 29. J Heart Lung Transplant. 2024. PMID: 37778526 Free article.
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
Ghofrani HA, Simonneau G, D'Armini AM, Fedullo P, Howard LS, Jaïs X, Jenkins DP, Jing ZC, Madani MM, Martin N, Mayer E, Papadakis K, Richard D, Kim NH; MERIT study investigators. Ghofrani HA, et al. Among authors: kim nh. Lancet Respir Med. 2024 Apr;12(4):e21-e30. doi: 10.1016/S2213-2600(24)00027-4. Lancet Respir Med. 2024. PMID: 38548406 Clinical Trial.
Catabolic metabolism during cancer EMT.
Cha YH, Yook JI, Kim HS, Kim NH. Cha YH, et al. Among authors: kim nh. Arch Pharm Res. 2015 Mar;38(3):313-20. doi: 10.1007/s12272-015-0567-x. Epub 2015 Jan 30. Arch Pharm Res. 2015. PMID: 25634102 Review.
2,366 results